Wilson wolf cell culture products for adoptive cell therapy
Ended Purchase Order Awarded Last action
- Contract number
- 75N91024P00558
- Awardee
-
Wilson Wolf Manufacturing, LLC UEI L1HKPVNJ33J8
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $699,861
Award facts
- Opportunity
-
- Brand Name Wilson Wolf Cell Culture Products for Adoptive Cell Therapy Solicitation · 75N91024CSS6900011 · Posted Jun 17, 2024
- Contract value 100% obligated
- $699,861.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 339112 Surgical and Medical Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 6 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Mounds View, MN 55112, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $65,000 | |
| Original award | $634,861 |
About this award
The National Cancer Institute awarded a $699,861.34 firm fixed-price purchase order to Wilson Wolf Manufacturing, LLC for cell culture products supporting the NCI Surgery Branch's adoptive cell transfer therapy program. The award, made on July 15, 2024, with a completion date of July 14, 2026, procures brand-name Wilson Wolf cell culture devices, specifically G-REX models (100 and 100M variants), which are manufactured under good manufacturing practices and FDA approval requirements. The solicitation, posted on June 17, 2024, was issued as an unrestricted competition with no set-aside designations, with award made to the lowest-priced technically acceptable offeror. Wilson Wolf Manufacturing, based in Mounds View, Minnesota, is a self-certified small disadvantaged business with extensive experience delivering specialized biological and medical supplies to federal agencies.
This contract directly supports cancer research and clinical treatment operations within the National Institutes of Health intramural research framework. Wilson Wolf Manufacturing has established itself as a key supplier to the NCI and broader NIH system, with a contract portfolio ranging from approximately $14,000 to nearly $700,000 across multiple firm fixed-price purchase orders. The company's G-REX gas-permeable cell culture devices are critical technologies for cellular therapy development and clinical applications, making this award a continuation of the vendor's specialized role in advancing NCI's cancer treatment and research capabilities through advanced cell culture technology procurement.
Quick answers
Who was awarded contract 75N91024P00558?
75N91024P00558 was awarded to Wilson Wolf Manufacturing, LLC by National Cancer Institute (National Institutes of Health) on July 15, 2024.
How much is contract 75N91024P00558 worth?
The government has obligated $699,861 on 75N91024P00558.
Was contract 75N91024P00558 competed?
The extent of competition for 75N91024P00558 was competed under sap. The government received 6 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award